Drug Trial Radar · NCT06757738
A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Jan 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
66
Actual
Start
Aug 13, 2024
Primary completion
Jan 16, 2025
Study completion Jan 24, 2025
Sponsor
- Lead sponsor
- Traws Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a clinical study aiming to assess pharmacokinetics, pharmacodynamics and preliminary efficacy of TRX-100 (and its major active metabolite TRX-101) in Healthy Volunteers
Conditions
- Healthy Volunteer Study
Interventions
TRX-100Drug
CEN inhibitor, dosage form - capsules, dosing regimen - QD
PlaceboDrug
Placebo, dosage form - capsules, dosing regimen - QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the safety and tolerability of a single oral administration of TRX-100Time frame: up to Day 28
- To assess the safety and tolerability of a single oral administration of TRX-100Time frame: up to Day 28
- To assess the safety and tolerability of a single oral administration of TRX-100Time frame: up to Day 28
- To assess the safety and tolerability of a single oral administration of TRX-100Time frame: up to Day 28
- To assess the safety and tolerability of a single oral administration of TRX-100Time frame: up to Day 28
- To assess the safety and tolerability of a single oral administration of TRX-100Time frame: up to Day 28
- To assess the safety and tolerability of a single oral administration of TRX-100 aTime frame: up to Day 28
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Scientia Clinical Research
Sydney, Greater Sydney Area, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.